Laurus Labs Limited
LAURUSLABS
Rang in Aktien
#1737
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktienkurs
$22.83
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$12.34B
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Laurus Labs Limited (LAURUSLABS)
Anzahl der ausstehenden Aktien zum June 2026: 539.79M
Laut den neuesten Finanzberichten und dem Aktienkurs von Laurus Labs Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 539.79M. Am Ende von March 2024 hatte das Unternehmen 540.57M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Laurus Labs Limited (LAURUSLABS) von 2013 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 539.79M | 0.03% |
| 2025 | 539.64M | -0.17% |
| 2024 | 540.57M | 0.16% |
| 2023 | 539.69M | 0.11% |
| 2022 | 539.10M | 0.19% |
| 2021 | 538.06M | 0.87% |
| 2020 | 533.42M | 0.13% |
| 2019 | 532.75M | 0.19% |
| 2018 | 531.76M | 16.15% |
| 2017 | 457.83M | -6.95% |
| 2016 | 492.04M | 10.95% |
| 2015 | 443.48M | 0.00% |
| 2014 | 443.48M | 9.11% |
| 2013 | 406.44M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 344.49% |
IN
|
